You've opened Binance Futures, found ANTHROPICUSDT – and something doesn't add up. No ticker on the NYSE, no page on Yahoo Finance. There are no shares. So what is this thing and how do you work with it?

In short: it's not a stock or a cryptocurrency in the usual sense. It's a synthetic perpetual contract, pegged to the valuation of the private AI company Anthropic – the very company that makes Claude. The company is not traded on the stock exchange. It never has been. Binance Futures is the only place on Earth where there's a public "chart" for this asset.

This changes everything. Let's break it down step by step.

Anthropic: Who Are They and Why Do They Need $61.5 Billion

Anthropic was founded in 2021 by Dario and Daniela Amodei – former OpenAI employees who left to build AI "the right way." Their focus is on Constitutional AI and a safety-first approach: model safety first, then power. Their direct competitors are OpenAI with GPT and Google DeepMind with Gemini.

Their product is the Claude family of models: Sonnet, Opus, Haiku. The target is the enterprise segment, where corporations pay for predictability and reliability, not for viral hype. Revenue, by rumors, is projected to exceed $1B ARR by the end of 2025.

The funding comes not from hyped-up funds, but from heavy artillery:

• Amazon – $4B+ investment plus AWS as the main computing platform
• Google – $2B+
• Salesforce, Spark Capital, and several others

In March 2026, the Series E round closed with a valuation of ~$61.5 billion. This isn't a startup with a slick pitch deck – it's a company where Amazon and Google have invested real billions with real expectations of return.

On paper, the story is strong. In practice – no IPO, no shares, no publicly traded asset. Except in one place.

Why Binance Is Anthropic's Only "Chart"

Here's the essence of this instrument. When you look at ANTHROPICUSDT, you're looking at a synthetic: Binance sets the price based on venture valuations from recent funding rounds. Not exchange quotes – those simply don't exist.

This leads to something important that half the reviews conveniently omit: there are no GAPS here. Regular equity perpetuals – say, MSFTUSDT or METAUSDT – follow the NASDAQ schedule. The market closes, opens with a gap – and you're either in profit or facing an unpleasant surprise. ANTHROPICUSDT trades 24/7, like a regular crypto perpetual. For a trader working in the Asian or night session, this is a real advantage.

But there's another side to this coin. The very side that breaks standard approaches.

How to Trade Here: Forget About MA Analysis

The standard setup for most traders is to wait for the price to break the 50MA, 200MA, form a support level, and enter with a clear stop. This approach doesn't work for ANTHROPICUSDT, and here's why.

The ticker is new. MA50, MA100, MA200 are either not formed or based on too short a history to be trusted. On 1h and 15m charts, it's noise: few participants, low liquidity, random movements. Entering with technical analysis here means your stops will be hit before you can blink.

The minimum timeframe for serious analysis is 4 hours. No less. Daily and weekly charts still have too few candles for statistically significant conclusions.

What instead of MA? An event-driven approach works here. This is an indicator coin for the AI industry – and it reacts to news, not to moving average crossovers.

What Really Moves ANTHROPICUSDT

Watch for these triggers:

• Model releases – launch of Claude 4, Claude 5, updates to Sonnet/Opus. A new model is a potential pump catalyst, especially if it beats competitor benchmarks.
• Partnerships – expansion of the AWS deal with Amazon, new Google Cloud agreements, major enterprise clients. Corporate money drives valuation.
• IPO rumors – the latest and main potential catalyst. When Anthropic announces preparations for an IPO, the synthetic will react first – because it's the company's only tradable "asset."
• AI regulatory news – EU AI Act, US executive orders, antitrust investigations. Bad news for the industry = a dump; easing = a buyback.
• Comparison with OPENAIUSDT – watch for cross-reactions. If GPT-5 is a flop – the Claude narrative strengthens. If the opposite, Anthropic faces pressure.

Who It's For, Who It's Not For

Suitable For

• Event-driven traders who follow AI news and understand the competitive landscape (Claude vs GPT vs Gemini).
• Those who trade on larger timeframes (4h+) and know how to wait for a trigger.
• Those who want exposure to the AI story through a liquid instrument without direct venture risk.

Not Suitable For

• Beginners – no familiar reference points, no "correct" price.
• Traders who rely solely on MA signals – this instrument is not for you; fundamentals are against it.
• Those who can't handle the psychological stress of 24/7 trading – no "weekends," the coin never sleeps.

Risks: No Sugarcoating

The risk section here is not a formal disclaimer, but a working tool.

• Valuation ≠ Market Cap. $61.5B is the venture valuation of the latest round, not the market price of a public company. The difference can be huge in either direction.
• An IPO may not happen. Or it might happen in 3 years. Or at a lower valuation than current – then the synthetic will correct sharply.
• Low liquidity at launch. The ticker is new – wider spreads, higher slippage, a large order moves the price more than on mature instruments.
• AI competition doesn't stand still. If Claude loses ground in the enterprise segment – the company's valuation plummets, and the synthetic follows.
• No exchange audit. A private company isn't obligated to publish quarterly reports. You're trading on limited information.

Conclusion

ANTHROPICUSDT is not just a "coin riding the AI hype." It's a bet on a private company valued at $61.5 billion, competing with OpenAI and Google for the enterprise market, and whose only public "chart" is this ticker on Binance.

There's nothing for MA traders here. For those who follow the AI industry, read news about Claude, and know how to trade on event-driven triggers – it's an interesting instrument. Especially when the first IPO rumors emerge.

This is not financial advice. Trading synthetic contracts involves increased risk.